期刊
SCIENCE CHINA-LIFE SCIENCES
卷 59, 期 4, 页码 360-369出版社
SCIENCE PRESS
DOI: 10.1007/s11427-016-5025-6
关键词
solid tumor; adoptive cell therapy; T cell; chimeric antigen receptor
类别
资金
- Supporting Programs of Research Fund of State Key Laboratory of Oncogenes and Related Genes [91-14-12]
- Shanghai Science and Technology Development Funds [12JC1408300]
- Shanghai Rising-Star Program (A type) [13QA1403300]
- One Hundred Talents Scientific Research Projects of Health Systems in Shanghai [XBR2013123]
Chimeric antigen receptors (CARs) are artificial recombinant receptors that generally combine the antigen-recognition domain of a monoclonal antibody with T cell activation domains. Recent years have seen great success in clinical trials employing CD19-specific CAR-T cell therapy for B cell leukemia. Nevertheless, solid tumors remain a major challenge for CAR-T cell therapy. This review summarizes the preclinical and clinical studies on the treatment of solid tumors with CAR-T cells. The major hurdles for the success of CAR-T and the novel strategies to address these hurdles have also been described and discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据